No Data
Will you be eliminated if you don't go overseas? In the first half of the year, the proportion of innovative drug outbound business development accounted for about 80% | Industry Dynamics.
①At the 2024 New Investment Conference hosted by Frost Sullivan, the issue of going global was favored by participants. ②There is a new trend in the export of innovative drugs in China, for example, the number of export BDs exceeded License-in for the first time in 2023. ③Some participating experts put forward rational opinions and called for internal strength, not just enthusiasm.
The market is booming as Johnson, an innovative drug company, sees a 13% increase in performance | Jiann zhiyan Research
The market should not lose confidence in China's innovative drugs.
BeiGene Stock Rises on FDA Fast Track Tag for Investigational Cancer Therapy
The growth rate of all channels of dressing in the second half of the year may be slightly lower than that in the first half. Juzi Biotech stated that it will continue to expand the number of terminal stores. Earnings conference coverage.
At the earnings conference, Juzi Biotech predicted that products such as wrinkle fillers may obtain registration certificates in the first quarter of next year. The company's secretary, Yan Yubo, stated that due to the impact of online growth, the overall growth rate of all channels of dressings may be slightly lower than the first half of the year. The company's CFO, Zhang Huijuan, expects that the growth rate in the CS/KA channel will further slow down in the second half of the year.
Unaudited Semi-annual Report 2024
The list of Hong Kong stock connect ETFs has been adjusted under the Shenzhen-Hong Kong stock connect. Added to the list are iShares Core MSCI China Index ETF (02801) and W.I.S.E. - CSI HK 100 Tracker (02825), among others.
On July 12th, the Shenzhen Stock Exchange announced the adjustment of the Hong Kong stock through train ETF list, adding iShares Core MSCI China Index ETF (02801), W.I.S.E. - CSI HK 100 Tracker (02825), CSOP FTSE China A50 ETF (03040), ChinaAMC Hang Seng Index ETF (03069), Ping An of China CSI HK Dividend ETF (03070), and iShares Core Hang Seng Index ETF (03115), which will take effect on July 22nd.